Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma

Novel rexinoid compound 6-Methyl-UAB30 demonstrates superior anti-tumor activity in neuroblastoma through multiple mechanisms including growth inhibition, differentiation induction, and stem cell marker suppression. Preclinical studies show decreased proliferation, cell cycle arrest, and improved survival in xenograft models, suggesting potential as a less toxic alternative to standard retinoic acid maintenance therapy.